15 insiders reported 37 Form 4 transactions for Scribe Therapeutics, Inc. (SCTX) over the past 18 months (most recent 2026-07-29). Recent activity: Doudna Jennifer A (10% Owner) Buy 12,511 shares, AH Equity Partners Bio II, L.L.C. (10% Owner) Buy 333,333 shares, OrbiMed Capital GP VIII LLC (Director) Buy 348,825 shares, AH Equity Partners Bio III, L.L.C. (10% Owner) Buy 2.1M shares, GORDON CARL L (Director) Buy 348,825 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Doudna Jennifer A | 10% Owner | Buy | 12,511 | $0 |
| 2026-07-29 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | OrbiMed Capital GP VIII LLC | Director | Buy | 348,825 | $0 |
| 2026-07-29 | AH Equity Partners Bio III, L.L.C. | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | GORDON CARL L | Director | Buy | 348,825 | $0 |
| 2026-07-29 | HOROWITZ BENJAMIN A | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | AH Bio Fund III, L.P. | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | AH Bio Fund II, L.P. | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | Andreessen Marc L | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | ORBIMED ADVISORS LLC | Director | Buy | 348,825 | $0 |
| 2026-07-29 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | OrbiMed Capital GP VIII LLC | Director | Buy | 1.0M | $15.0M |
| 2026-07-29 | ORBIMED ADVISORS LLC | Director | Buy | 1.0M | $15.0M |
| 2026-07-29 | Andreessen Marc L | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | AH Bio Fund III, L.P. | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | HOROWITZ BENJAMIN A | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | GORDON CARL L | Director | Buy | 1.0M | $15.0M |
| 2026-07-29 | AH Bio Fund II, L.P. | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | AH Equity Partners Bio III, L.L.C. | 10% Owner | Buy | 697,650 | $0 |
| 2026-07-29 | AH Bio Fund II, L.P. | 10% Owner | Buy | 2.1M | $0 |
| 2026-07-29 | AH Equity Partners Bio III, L.L.C. | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | Andreessen Marc L | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | HOROWITZ BENJAMIN A | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | AH Bio Fund III, L.P. | 10% Owner | Buy | 333,333 | $5.0M |
| 2026-07-29 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Buy | 2.1M | $0 |
Source: SEC Form 4 filings · as of 2026-07-29